468 related articles for article (PubMed ID: 27914497)
1. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
Xian Y; Hernandez AF; Harding T; Fonarow GC; Bhatt DL; Suter RE; Khan Y; Schwamm LH; Peterson ED
Am Heart J; 2016 Dec; 182():28-35. PubMed ID: 27914497
[TBL] [Abstract][Full Text] [Related]
2. Trends and Characteristics of Emergency Department Patients Prescribed Novel Oral Anticoagulants.
Ganetsky M
J Emerg Med; 2015 Nov; 49(5):693-7. PubMed ID: 26149803
[TBL] [Abstract][Full Text] [Related]
3. Non-Vitamin K Antagonist Oral Anticoagulants and Factors Influencing the Ischemic and Bleeding Risk in Elderly Patients With Atrial Fibrillation: A Review of Current Evidence.
Patti G; Haas S
J Cardiovasc Pharmacol; 2020 Oct; 77(1):11-21. PubMed ID: 33060545
[TBL] [Abstract][Full Text] [Related]
4. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
[TBL] [Abstract][Full Text] [Related]
5. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
Koziński M; Obońska K; Kubica A; Navarese EP; Kubica J
Kardiol Pol; 2012; 70(10):1053-60. PubMed ID: 23080100
[No Abstract] [Full Text] [Related]
6. Perioperative management of patients on new oral anticoagulants.
Lai A; Davidson N; Galloway SW; Thachil J
Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
[TBL] [Abstract][Full Text] [Related]
7. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.
Loffredo L; Perri L; Violi F
Dig Liver Dis; 2015 May; 47(5):429-31. PubMed ID: 25732432
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the efficacy and safety of new oral anticoagulant drugs in the secondary stroke prevention in patients with AF: single center experience based on 311 patients.
Lasek-Bal A; Urbanek T; Gierek D
Int Angiol; 2015 Dec; 34(6):552-61. PubMed ID: 25410296
[TBL] [Abstract][Full Text] [Related]
9. Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.
Takizawa S; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Mizuma A; Yutani S; Nakayama T; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K;
J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2143-8. PubMed ID: 26153510
[TBL] [Abstract][Full Text] [Related]
10. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
11. Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons.
Verdecchia P; Angeli F; Lip GY; Reboldi G
PLoS One; 2014; 9(6):e100478. PubMed ID: 24955573
[TBL] [Abstract][Full Text] [Related]
12. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants.
Sivolella S; De Biagi M; Brunello G; Berengo M; Pengo V
Odontology; 2015 Sep; 103(3):258-63. PubMed ID: 25656043
[TBL] [Abstract][Full Text] [Related]
13. Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin.
Coleman CM; Khalaf S; Mould S; Wazni O; Kanj M; Saliba W; Cantillon D
Pacing Clin Electrophysiol; 2015 Jun; 38(6):731-7. PubMed ID: 25721150
[TBL] [Abstract][Full Text] [Related]
14. Antidotes to non-vitamin K oral anticoagulants: necessary or not?
Proietti M; Lip GY
Expert Opin Pharmacother; 2015; 16(11):1573-6. PubMed ID: 26077323
[TBL] [Abstract][Full Text] [Related]
15. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
16. Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study.
Lehto M; Luojus A; Halminen O; Haukka J; Putaala J; Linna M; Mustonen P; Kinnunen J; Lehtonen O; Teppo K; Tiili P; Kouki E; Itäinen-Strömberg S; Niemi M; Aro AL; Hartikainen J; Airaksinen KEJ;
Ann Med; 2024 Dec; 56(1):2364825. PubMed ID: 38873855
[TBL] [Abstract][Full Text] [Related]
17. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.
Sardar P; Chatterjee S; Lavie CJ; Giri JS; Ghosh J; Mukherjee D; Lip GY
Int J Cardiol; 2015 Jan; 179():279-87. PubMed ID: 25464465
[TBL] [Abstract][Full Text] [Related]
18. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
Banerjee A; Lane DA; Torp-Pedersen C; Lip GY
Thromb Haemost; 2012 Mar; 107(3):584-9. PubMed ID: 22186961
[TBL] [Abstract][Full Text] [Related]
19. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip GY; Larsen TB; Skjøth F; Rasmussen LH
J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
[TBL] [Abstract][Full Text] [Related]
20. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]